Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients with diabetes: results of the POWER survey
Robert J Petrella,1–3 Dawn P Gill,2,3 Jean-Pascal Berrou4On behalf of the POWER survey Study Group 1Departments of Family Medicine, Medicine (Cardiology) and Kinesiology, University of Western Ontario, London, ON, Canada; 2Aging, Rehabilitation and Geriatric Care Research Centre,...
Guardado en:
Autores principales: | Petrella RJ, Gill DP, Berrou JP |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/840d2732eb7942baa09e580f317ba571 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
por: Da Costa LA, et al.
Publicado: (2012) -
Arab Teens Lifestyle Study (ATLS): objectives, design, methodology and implications
por: Musaiger AO; ATLS Research Group, et al.
Publicado: (2011) -
Cardiometabolic results from an armband-based weight loss trial
por: Sieverdes JC, et al.
Publicado: (2011) -
Effects of body mass index-related disorders on cognition: preliminary results
por: Yesavage JA, et al.
Publicado: (2014) -
Nomogram Based on Risk Factors for Type 2 Diabetes Mellitus Patients with Coronary Heart Disease
por: Shi R, et al.
Publicado: (2020)